FROG Q1 2026 Earnings EPS Beats Estimates by 24 Stock Rises Modestly PHI Q1 2026 Earnings EPS Misses Estimates but Stock Inches Higher MDLN Q1 2026 Earnings EPS Beats Estimates by 95 Stock Edges Higher Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses NTRSO Q1 2026 Earnings Strong EPS Beat Drives Slight Share Uptick OCCIN Q1 2026 Earnings Preferred Stock Reports Steep EPS Miss as Net Investment Income Falls Short